ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC82.6

C82.6

Billable

Cutaneous follicle center lymphoma

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C82.6 is a billable code used to indicate a diagnosis of cutaneous follicle center lymphoma.

Key Diagnostic Point:

Cutaneous follicle center lymphoma (CFCL) is a type of non-Hodgkin lymphoma that primarily affects the skin. It is characterized by the proliferation of B-cells in the follicle center, leading to the formation of nodules or plaques on the skin. CFCL is considered a low-grade lymphoma, often presenting with indolent symptoms. Patients may experience localized skin lesions, which can be mistaken for other dermatological conditions. The disease is typically diagnosed through skin biopsy, where histological examination reveals neoplastic follicle center cells. Staging of CFCL is crucial, as it can influence treatment decisions. The Ann Arbor staging system is commonly used, which assesses the extent of disease involvement in the skin and lymph nodes. B-symptoms, such as fever, night sweats, and weight loss, may be present but are less common in CFCL compared to other lymphomas. Treatment options vary based on disease stage and may include topical therapies, radiation, and systemic therapies such as chemotherapy or immunotherapy. The prognosis for patients with CFCL is generally favorable, especially when diagnosed early and treated appropriately.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiation from other skin lymphomas
  • Need for accurate staging
  • Potential overlap with other dermatological conditions
  • Variability in treatment protocols based on disease stage

Audit Risk Factors

  • Inadequate documentation of staging
  • Failure to document B-symptoms
  • Misclassification of skin lesions
  • Lack of follow-up documentation

Specialty Focus

Medical Specialties

Hematology/Oncology

Documentation Requirements

Detailed clinical notes on staging, treatment response, and follow-up care.

Common Clinical Scenarios

Diagnosis and management of CFCL, treatment planning, and monitoring for recurrence.

Billing Considerations

Ensure accurate staging and documentation of any B-symptoms to guide treatment.

Dermatology

Documentation Requirements

Comprehensive skin examination notes, biopsy results, and treatment plans.

Common Clinical Scenarios

Evaluation of skin lesions, biopsy for diagnosis, and management of skin-related symptoms.

Billing Considerations

Differentiating CFCL from other dermatological conditions is crucial for accurate coding.

Coding Guidelines

Inclusion Criteria

Use C82.6 When
  • Follow the official ICD
  • CM coding guidelines, ensuring accurate documentation of the diagnosis, staging, and any associated symptoms
  • Include details on treatment plans and responses

Exclusion Criteria

Do NOT use C82.6 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

88305CPT Code

Pathology consultation

Clinical Scenario

Used when a biopsy is performed to confirm CFCL diagnosis.

Documentation Requirements

Pathology report must be included in the patient's medical record.

Specialty Considerations

Ensure the pathology report clearly indicates the diagnosis of CFCL.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of cutaneous lymphomas, improving the accuracy of data collection and treatment tracking. It has also facilitated better understanding of the disease's epidemiology and treatment outcomes.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of cutaneous lymphomas, improving the accuracy of data collection and treatment tracking. It has also facilitated better understanding of the disease's epidemiology and treatment outcomes.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of cutaneous lymphomas, improving the accuracy of data collection and treatment tracking. It has also facilitated better understanding of the disease's epidemiology and treatment outcomes.

Resources

Clinical References

  • •
    National Comprehensive Cancer Network (NCCN) Guidelines

Coding & Billing References

  • •
    National Comprehensive Cancer Network (NCCN) Guidelines

Frequently Asked Questions

What are the common symptoms of cutaneous follicle center lymphoma?

Common symptoms include solitary or multiple skin lesions, which may be nodular or plaque-like. Some patients may experience mild itching or discomfort, but systemic symptoms like fever and weight loss are less common.